2022.01.19 05:29 TheAssasin66 Does the world even listen to scientists when they warm people about climate change example?
Like its just one of many examples like scientists are warning of endangered species or global warming, or melting of ice caps. You always see that over the news and how it could be alarming for the next decade or so, but is anything actually be done from it besides the documentation and research? Now im not dissing the scientists for publicizing their research but what is actually being done anyways? I dont have any experience in any of these fields but i feel like nothings happening really. We are using electric now which is good but still emitting greenhouse gas emissions etc.
submitted by TheAssasin66 to NoStupidQuestions [link] [comments]
2022.01.19 05:29 royalfavor LF: Spheal TF: Cranidos/Elekid/Feebas
2022.01.19 05:29 AutoNewspaperAdmin [ZA] - WATCH: By-standers loot money from blown up cash van after dramatic Cape Town robbery and shoot-out | IOL
|submitted by AutoNewspaperAdmin to AutoNewspaper [link] [comments]|
2022.01.19 05:29 NewsCryptocurrency Class Or Bling? How Jewelery Can Win Friends And Influence People
2022.01.19 05:29 bruhex fucking adorable
|submitted by bruhex to youngpeoplereddit [link] [comments]|
2022.01.19 05:29 afropoppa Anyone taken a paid PCR for travel test recently?
2022.01.19 05:29 zippoman1118 Do you start eating deep fried shrimp from the head or tail?
Hey reddit friends, I was eating some good deep fried shrimp (Japanese jumbo prawns) with my friend. She picked it up by the head (meat side) and started chomping away from the tail. Me being Japanese, I watched in horror as this transpired before me.I've never seen anyone eat like this and pointed it out to her. We got into a debate about this for awhile and she even asked her whole familly, in which they all replied how they are able to eat from the tail or some members even would strongly stand on eating from the tail first.
I understand this is a ridiculous detail that doesn't really matter but for the sake of the argument.
Deep fried shrimp from head? (Meat side first) Or deep fried shrimp from the tail? (Apparently the better crispy side)
submitted by zippoman1118 to AskRedditFood [link] [comments]
2022.01.19 05:29 Brammie_ Taken down at 22k , TikTok he’s okay . Stop
|submitted by Brammie_ to QuceeHumor [link] [comments]|
2022.01.19 05:29 PieterJanSmet Thanks, I hate microwaves now
|submitted by PieterJanSmet to TIHI [link] [comments]|
2022.01.19 05:29 SituationLive4406 $IMMX CTB AVG 225% APR with 100% utilization 4.12M share float - Shares on Loan 670K all from Ortex Data as of 01-18-22
IMMIX Biopharma (IMMX) Looks Like it has Plenty of Room to Grow its Value
Good day everyone,
Immix Biopharma, Inc. (NASDAQ: IMMX) a biopharmaceutical company pioneering a novel class of Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases.
After closing at $5.84/share in the Friday session, IMMX shares opened lower today at $5.55. The market indices are struggling this morning and we hope that will turn around. In the first 30 minutes of trading IMMX share are above the open but lag the prior sessions close.
IMMX is not the only development/clinical stage company with a novel platform for cancer treatment. I looked at a few of the others and came to two conclusions and maybe you will agree:
I think the IMMX SMARxT Platform has more potential.
IMMX has a lot of room to grow its value.
C4 Therapeutics (CCCC) MV $1.33B
Adaptimmune Therapeutics (ADAP) MV $515M
Immix Biopharma (IMMX) MV $44M
Biolata (BCAB) MV $465M
An IMMX Investors Day Event, will be held on February 1, 2022, and the launch of an online Q&A platform for all shareholders to submit questions in advance. IMMX shareholders can submit and upload questions to be answered at the event. To submit questions, please visit https://immixbio.com/QA. The Q&A platform will remain open until 5:00pm ET on Thursday, January 20. The live webcast will be available on the Investor Relations website at https://immixbio.com/IR. Following the event, a replay of the event, as well as a transcript, will be available on the same website.
To me, hosting a Q&A session so soon after their IPO indicates a high level of confidence.
IMMX shares exploded two weeks ago and have maintained their higher pricing level. Why?
Immix Biopharma, Inc. (NASDAQ: IMMX) is a clinical-stage biopharmaceutical company pioneering a novel class of Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases.
Current price $5.81/share (as of market close 1-18-22)
We wanted to report on IMMX because it’s a new IPO in the biopharma sector and we want to explore their potential. The company announced that its shares began trading on the NASDAQ on December 16th and the IPO closed on December 20th with an offering of 4,200,000 shares of its common stock at a price of $5.00 per share, for gross proceeds of $21M.
The IPO is less than a month old and like often happens, the company shares declined over the first couple weeks to under $3.50/share. On January 3rd the company announced its lead product candidate, IMX-110 was granted Rare Pediatric Disease (RPD) designation by the Food and Drug Administration for the treatment of pediatric cancer.
IMMX shares more than doubled on the news, closed that day at $5.78/share and have remained near that price range since. A quick check of the IMMX stock chart will show the narrow range the shares have traded in for the past two weeks. Will the company value stay in this narrow range? I think not, I believe it’s going higher and what I say below is why.
Firstly, IMMX has a tiny share structure (7.5M outstanding and only 1.29M in the float) and insiders own 44.6% of the outstanding shares. Altium Capital Management is already in for an 8.27% stake. Competition for IMMX shares is intensifying.
As you read about the IMMX platform below, keep in mind that as of this writing, the company market value is less that $50M and compare that to other companies you know of with promising oncology treatments in development.
The second reason interest is growing in IMMX shares is their novel technology. IMMX is developing a new class of Tissue-Specific Therapeutics, or TSTx, which they believe will replace first-line therapies across a multitude of oncology indications.
That press release on January 3rd opened investor’s eyes to the IMMX cancer treatment technology. It’s new, novel, and quite amazing. As investor awareness grows, I believe the company will grow. To me, it seems like the FDA is already looking favorably toward the IMMX technology.
Their SMARxT Platform produces Tissue-Specific Therapies, which in cancer target all three components (1. cancer associated fibroblasts, 2. tumor-associated macrophages/immune cells, and 3. cancer itself), of the TME simultaneously, severing the critical lifelines between the tumor and its metabolic support.
You will learn more about the IMMX SMARxT Platform by visiting the resources I’ve listed below but, briefly, the IMMX technology starves a cancer tumor of the nutrients it needs to survive and grow, effectively killing it.
Just last Wednesday the company informed that “ImmixBio IMX-110 Produced 50% Positive Response Rate in First-Line-Therapy-Resistant Cancer, Surpassing the Standard of Care in Mice Study.” That 50% is an impressive positive response rate. The data was generated after 1 cycle of treatment as a monotherapy in first line-therapy-resistant cancer - soft tissue sarcoma (STS) mouse study. Clinical treatment for STS, is a $3 billion market expected to grow to $6.5 billion by 2030.
Just to underscore the significance of the animal study above, Doxorubicin, a cancer treatment that IMMX may compete with, one with over $1B in revenues, had a response rate of 0% after 1 cycle of treatment in the same study.
Watch this short video that describes the function of their IMX-110 product and review the presentation linked below to familiarize yourself with this new approach to cancer treatment. I’m certain that savvy investors are doing it.
In the chart below you can see the three products in development at IMMX. As a part of your due diligence, you can review the company presentation.
IMMX was incorporated in California in 2012 so they have been developing their technology for a while. They also have a wholly owned Australian subsidiary, Immix Biopharma Australia Pty Ltd., to conduct various pre-clinical and clinical activities for the development of product candidates.
The potential for growth in value at IMMX is not only likely, but I also believe it could be exponential. As you study their SMARxT Platform you may understand why the competition for that tiny 1.29M share float is getting competitive.
submitted by SituationLive4406 to WallstreetSluts [link] [comments]
2022.01.19 05:29 AutoNewspaperAdmin [ZA] - Back to school: Capetonians spread the spirit of ubuntu by giving out school uniforms | IOL
|submitted by AutoNewspaperAdmin to AutoNewspaper [link] [comments]|
2022.01.19 05:29 punctuationist [i ate] shrimp poke with sparkling mineral water
|submitted by punctuationist to food [link] [comments]|
2022.01.19 05:29 Arnadus [KROM] Kromatika. Price ↘ -2.72% in 5 minutes
2022.01.19 05:29 Vegetable_Jump_9321 Can someone tell me what these weird bumps are? They're mostly on my chest and back, never got them on my face before
|submitted by Vegetable_Jump_9321 to SkincareAddicts [link] [comments]|
2022.01.19 05:29 dharc__ I wanna test something out
2022.01.19 05:29 Memer6969-3000 Lancer Cu Chulainn dies over and over again in Death Battle
|submitted by Memer6969-3000 to DeathBattleMatchups [link] [comments]|
2022.01.19 05:29 whatisaweirdquestion What are the chances of being born on a full moon
2022.01.19 05:29 CamG9_ Capsized truck on Bridgeman Rd!
|submitted by CamG9_ to brisbane [link] [comments]|
2022.01.19 05:29 ripuik So I just joined. What a warm welcome.
|submitted by ripuik to RLSideSwipe [link] [comments]|
2022.01.19 05:29 eDgE_031 This is my ICD (Implantable Cardioverter Defibrillator). It saved my life last week! [OC]
|submitted by eDgE_031 to pics [link] [comments]|
2022.01.19 05:29 Zealous-Road138 Showing off her arms
|submitted by Zealous-Road138 to leanbeefpatty [link] [comments]|
2022.01.19 05:29 Fuzzy452 Nami can’t wear boots
If Cassiopeia has a movement speed passive because she can’t wear boots why does nami still buy boots? Where does she put them? On her hands like mittens? She’s a freaking mermaid she can’t wear boots riot pls
submitted by Fuzzy452 to NamiMains [link] [comments]
2022.01.19 05:29 ZenPhotoDen Angry pirates and angry women
2022.01.19 05:29 Aedenn_333 Hoya linearis black spots, any idea what it is / how to treat it? It’s been like this for a while
2022.01.19 05:29 Joyeshaa Ever wonder why there isn't daily tasks tin and money (the beginning) box reward???